pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukem...

por Patel, S, Guerenne, L, Gorombei, P, Omidvar, N, Schlageter, M-H, Alex, A A, Ganesan, S, West, R, Adès, L, Mathews, V, Krief, P, Pla, M, Fenaux, P, Chomienne, C, Padua, R A
Publicado 2015